Santo Remedios Piel Eterna Radiance Sunscreen Primer Spf-42 Lotion
NDC Package 81352-321-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Santo Remedios Piel Eterna Radiance Sunscreen Primer Spf-42 (titanium dioxide, zinc oxide) lotions is apply liberally 15 minutes before sun exposure and as needed.Children under 6 months of age: ask a doctor.Reapply:after 80 minutes of swimming or sweatingimmediately after towel dryingat least every 2 hoursSun Protection Measures.Spending time in the sun increases your risk of skin cancer and early skin aging. This formulation utilizes a lotion delivery system. Marketed by Santo Remedio Llc, this product is identified by NDC 81352-321 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
81352-321-00
Package Description
50 mL in 1 TUBE
Product Code
81352-321
11-Digit Billing Format
81352032100

Clinical Specifications

Proprietary Name
Santo Remedios Piel Eterna Radiance Sunscreen Primer Spf-42
Non-Proprietary Name
Titanium Dioxide, Zinc Oxide
Substance Name
Titanium Dioxide; Zinc Oxide
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Apply liberally 15 minutes before sun exposure and as needed.Children under 6 months of age: ask a doctor.Reapply:after 80 minutes of swimming or sweatingimmediately after towel dryingat least every 2 hoursSun Protection Measures.Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease the risk, regularly use sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:Limit time in the sun, especially from 10 a.m. - 2 p.m.Wear long-sleeved shirts, pants, hats, and sunglasses.

Regulatory & Marketing

Labeler Name
Santo Remedio Llc
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-21-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81352-321-00 identifies a specific commercial package of 50 ml in 1 tube of Santo Remedios Piel Eterna Radiance Sunscreen Primer Spf-42, a human over the counter drug labeled by Santo Remedio Llc. This lotion is formulated for topical use and contains titanium dioxide; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Santo Remedio Llc on March 21, 2022. The current certification is valid through December 31, 2026.

How is this Santo Remedio Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81352032100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81352-321-00
11-Digit CMS (5-4-2)
81352-0321-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.